International Journal of Clinical Pharmacy

, Volume 38, Issue 1, pp 135–143 | Cite as

Knowledge that people with intellectual disabilities have of their inhaled asthma medications: messages for pharmacists

  • Sharon R. Davis
  • Seeta Durvasula
  • Diana Merhi
  • Paul M. Young
  • Daniela Traini
  • Sinthia Z. Bosnic Anticevich
Research Article

Abstract

Background Fifteen percent of Australians with intellectual disability (ID) are reported to have asthma. People with ID are at risk of poor health knowledge due to deficits in intellectual and adaptive functioning, but their medication knowledge has largely been ignored in research to date. Objective To explore the level of understanding of asthma medication use of people with ID who self-administer their inhaled medications, in order to inform future educational support. Setting The research was conducted in NSW, Australia, at the participants’ homes, the point of health care access, or the offices of relevant support organisations. Method In this qualitative study face-to-face interviews were conducted with people with ID using a semi-structured interview guide. The interviews were recorded, transcribed and thematically analysed. Main outcome Identification of barriers to asthma medication self-management by people with ID. Results Seventeen people with ID who self-administer their asthma medications were interviewed. Factors influencing their asthma medication knowledge and use included understanding of their illness and the need for medication; aspects of self-management and autonomy versus dependence. This sample of people with ID had a good understanding of the importance of using their inhaled asthma medications, as well as asthma triggers, and the difference between use of preventer and reliever medications. Both enablers and barriers to asthma medication self-management were identified in the domains of managing attacks, adherence, knowledge of side effects and sources of information on correct use of inhalers. The level of autonomy for medication use varied, with motivation to self-manage asthma influenced by the level of support that was practically available to individual participants. Conclusion This research investigated aspects of asthma medication self-management of people with ID. Based on the barriers identified, pharmacists should promote use of spacers and written asthma action plans as well as counsel people with ID about how to recognise and minimise side effects of asthma medications. Specific strategies for pharmacists when educating people with ID and their caregivers include active listening to determine understanding of concepts, exercising care with language, and working with the person’s known routines to maximise adherence with preventer medications.

Keywords

Asthma Caregivers Inhaler Intellectual disability Interviews Pharmacists Qualitative research Self-management 

Notes

Acknowledgments

The authors wish to thank the disability support organisations that assisted with recruitment for this study.

Funding

No specific funding was received for this project.

Conflicts of interests

The authors declare no conflicts of interest.

References

  1. 1.
    National Asthma Council Australia. Australian asthma handbook, version 1.0. National Asthma Council Australia, Melbourne, 2014.Google Scholar
  2. 2.
    Australian Bureau of Statistics (2013c). Australian health survey: health service usage and health related actions, 2011–12. [Internet] 2013 Apr 15. [cited 2015 Mar 20]. Available from http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4364.0.55.0022011-12?OpenDocument.
  3. 3.
    Sapra S, Nielsen K, Martin BC. The net cost of asthma to North Carolina Medicaid and the influence of comorbidities that drive asthma costs. J Asthma. 2005;42(6):469–77.CrossRefPubMedGoogle Scholar
  4. 4.
    Wen X. Estimates of prevelance of intellectual disability in Australia. J Intellect Dev Disabil. 2004;29:284–9.CrossRefGoogle Scholar
  5. 5.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-V-TR. Washington: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  6. 6.
    Daily DK, Ardinger HH, Holmes GE. Identification and evaluation of mental retardation. Am Fam Physician. 2000;61(4):1059–67.PubMedGoogle Scholar
  7. 7.
    Harris JC. Intellectual disability: understanding its development, causes, classification, evaluation, and treatment. New York: Oxford University Press; 2006.Google Scholar
  8. 8.
    Australian Institute of Health and Welfare 2008. Disability in Australia: intellectual disability. AIHW cat. no. AUS 110, AIHW, Canberra.Google Scholar
  9. 9.
    Sturdy PM, Victor CR, Anderson HR, Bland JM, Butland BK, Harrison BDW, et al. Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study. Thorax. 2002;57:1034–9.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Davis SR, Durvasula S, Merhi D, Young PM, Traini D, Bosnic-Anticevich SZ. Respiratory medication use in an Australian developmental disability clinic population: messages for health care professionals. Aust J Prim Health. 2014;20:278–84.CrossRefPubMedGoogle Scholar
  11. 11.
    Huneke NTM, Gupta R, Halder N, Chaudry N. Difficult decisions: are intellectually disabled patients given enough information to consent to medical treatment? J Intellect Disabil. 2012;16(4):265–74.CrossRefPubMedGoogle Scholar
  12. 12.
    Turk V, Khattran S, Kerry S, Corney R, Painter K. Reporting of health problems and pain by adults with an intellectual disability and by their carers. J Appl Res Intellect Disabil. 2012;25:155–65.CrossRefPubMedGoogle Scholar
  13. 13.
    Arscott K, Stenfert Kroese B, Dagnan D. A study of the knowledge that people with intellectual disabilities have of their prescribed medication. J Appl Res Intellect Disabil. 2000;13:90–9.CrossRefGoogle Scholar
  14. 14.
    Strydom A, Hall I. Randomized trial of psychotropic medication information leaflets for people with intellectual disability. J Intellect Disabil Res. 2001;45(2):146–51.CrossRefPubMedGoogle Scholar
  15. 15.
    Creer TL. Behavioral and cognitive processes in the self-management of asthma. J Asthma. 2008;45:81–94.CrossRefPubMedGoogle Scholar
  16. 16.
    Smith L, Bosnic-Anticevich S, Mitchell B, Saini B, Krass I, Armour C. Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Soc Sci Med. 2007;64:1501–11.CrossRefPubMedGoogle Scholar
  17. 17.
    Smith SC, Mitchell C, Bowler S. Patient-centred education: applying learner-centred concepts to asthma education. J Asthma. 2007;44:799–804.CrossRefPubMedGoogle Scholar
  18. 18.
    Ziviani J, Lennox N, Allison H, Lyons M, Del Mar C. Meeting in the middle: improving communication in primary health care consultations with people with an intellectual disability. J Intellect Dev Disabil. 2004;29(3):211–25.CrossRefGoogle Scholar
  19. 19.
    DiBlasi A, Kendall S, Spark MJ. Perspectives on the role of the community pharmacist in the provision of health care to people with intellectual disabilities: exploration of the barriers and solutions. Int J Pharm Pract. 2006;14:263–9.CrossRefGoogle Scholar
  20. 20.
    Erikson SR, LeRoy B. Health literacy and medication administration performance by caregivers of adults with developmental disabilities. J Am Pharm Assoc. 2015;55(2):52–60.Google Scholar
  21. 21.
    Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, editors. Analyzing qualitative data. London: Routledge; 1994. p. 173–194.CrossRefGoogle Scholar
  22. 22.
    Paasche-Orlow MK, Riekert KA, Bilderback A, Chanmugam A, Hill P, Rand C, et al. Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med. 2005;172:980–6.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Finlay WML, Lyons E. Methodological issues in interviewing and using self-report questionnaires with people with mental retardation. Psychol Assess. 2001;13:319–35.CrossRefPubMedGoogle Scholar
  24. 24.
    Dodd K. Feeling poorly: report of a pilot study aimed to increase the ability of people with learning disabilities to understand and communicate about physical illness. Br J Learn Disabil. 1999;27:10–5.CrossRefGoogle Scholar
  25. 25.
    Williams MV, Baker DW, Honig EG, Lee TM, Nowlan A. Inadequate literacy is a barrier to asthma knowledge and self-care. Chest. 1998;114:1008–15.CrossRefPubMedGoogle Scholar
  26. 26.
    Young AF, Naji S, Kroll T. Support for self-management of cardiovascular disease by people with learning disabilities. Fam Pract. 2012;29:467–75.CrossRefPubMedGoogle Scholar
  27. 27.
    van Asselt-Goverts AE, Embregts PJCM, Hendriks AHC. Structural and functional characteristics of the social networks of people with mild intellectual disabilities. Res Dev Disabil. 2013;34:1280–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Cheong LH, Armour CL, Bosnic-Anticevich SZ. Patient asthma networks: understanding who is important and why. Health Expect. 2014;. doi: 10.1111/hex.12231.PubMedGoogle Scholar
  29. 29.
    Sibbald B. Patient self care in acute asthma. Thorax. 1989;44:97–101.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Andrews KL, Jones SC, Mullan J. Stigma: still an important issue for adults with asthma. J Asthma Allergy Educ. 2013;4(4):165–71.CrossRefGoogle Scholar
  31. 31.
    Guss D, Barash IA, Castillo EM. Characteristics of spacer device use by patients with asthma and COPD. J Emerg Med. 2008;35(4):357–61.CrossRefPubMedGoogle Scholar
  32. 32.
    Australian Medicines Handbook Pty Ltd. Australian Medicines Handbook (online). [Internet]. Adelaide; 2015 [cited 2015 Mar 4]. Available from http://amhonline.amh.net.au/.
  33. 33.
    Wong JG, Clare ICH, Holland AJ, Watson PC, Gunn M. The capacity of people with a ‘mental disability’ to make a health care decision. Psychol Med. 2000;30:295–306.CrossRefPubMedGoogle Scholar
  34. 34.
    Gibson PG, Powell H, Wilson A, Abramson MJ, Haywood P, Bauman A et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2009; (3).Google Scholar
  35. 35.
    Davis SR. Medication reviews for people with developmental disability—a call to action (letter). J Pharm Pract Res. 2014;44:159–63.CrossRefGoogle Scholar
  36. 36.
    Asthma UK. Easy to read materials. [Internet] 2011 Feb [cited 2015 Mar 16] Available from http://www.asthma.org.uk/Sites/healthcare-professionals/pages/easy-to-read-materials.
  37. 37.
    Boardman L, Bernal J, Hollins S. Communicating with people with intellectual disabilities: a guide for general psychiatrists. Adv Psychiatr Treat. 2014;20(1):27–36.CrossRefGoogle Scholar
  38. 38.
    Rasartnam R, Crouch K, Regan A. Attitude to medication of parents/primary carers of people with intellectual disability. J Intellect Disabil Res. 2004;48(8):754–63.CrossRefGoogle Scholar
  39. 39.
    Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, et al. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Inhaler Error Steering Committee. Respir Med. 2013;107(1):37–46.CrossRefPubMedGoogle Scholar
  40. 40.
    Davis SR, Durvasula S, Merhi D, Young PM, Traini D, Bosnic-Anticevich SZ. The ability of people with intellectual disability to use inhalers–an exploratory mixed methods study. J Asthma. 2015;. doi: 10.3109/02770903.2015.1065423.Google Scholar
  41. 41.
    McDonnell J, McFarland S. A comparison of forward and concurrent chaining strategies in teaching laundromat skills to students with severe handicaps. Res Dev Disabil. 1988;9:177–94.CrossRefPubMedGoogle Scholar
  42. 42.
    Primeau MS, Frith KH. Teaching patients with an intellectual disability. Nursing. 2013;43(6):68–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Brennan VK, Osman LM, Graham H, Chritchlow A, Everard ML. True device compliance: the need to consider both competence and contrivance. Resp Med. 2005;99(1):97–102.CrossRefGoogle Scholar
  44. 44.
    Melani S, Zanchetta D, Barbato N, Sestini P, Cinti C, Canessa PA, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol. 2004;93(5):439–46.CrossRefPubMedGoogle Scholar
  45. 45.
    Australian Bureau of Statistics. Australian Health Survey: Health service usage and health related actions, 2011–2012. Table 7. [Internet] 2013 Apr 15. [cited 2015 Mar 20]. Available from http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4364.0.55.0022011-12?OpenDocument.
  46. 46.
    Davis SR, Durvasula S, Merhi D, Young PM, Traini D, Bosnic-Anticevich SZ. The role of direct support professionals in asthma management. J Intellect Dev Disabil. 2015;40(4):342–53. doi: 10.3109/13668250.2015.1041100.CrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  • Sharon R. Davis
    • 1
  • Seeta Durvasula
    • 2
  • Diana Merhi
    • 3
  • Paul M. Young
    • 1
  • Daniela Traini
    • 1
  • Sinthia Z. Bosnic Anticevich
    • 1
    • 4
  1. 1.Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical SchoolThe University of SydneyCamperdownAustralia
  2. 2.Centre for Disability Studies, Sydney Medical SchoolUniversity of SydneyCamperdownAustralia
  3. 3.Synergy Medical PracticeGreenwichAustralia
  4. 4.Sydney Local Health DistrictSydneyAustralia

Personalised recommendations